133 related articles for article (PubMed ID: 11943900)
21. Acute nonlymphocytic leukemia after radiation and MOPP chemotherapy for Hodgkin's disease.
Lavey RS
J Clin Oncol; 1990 Dec; 8(12):2089-90. PubMed ID: 2230901
[No Abstract] [Full Text] [Related]
22. Transient optic neuropathy secondary to MOPP chemotherapy in Hodgkin's disease: report of a case.
Vecchi V; Maccolini E; Oddo Bravetti G; Guidelli Guidi S; Serra L
Tumori; 1984 Dec; 70(6):571-3. PubMed ID: 6549418
[TBL] [Abstract][Full Text] [Related]
23. Treatment of childhood Hodgkin's disease with chemotherapy alone. Experiences from the Royal Children's Hospital, Melbourne.
Ekert H
Cancer Treat Res; 1989; 41():241-6. PubMed ID: 2484293
[No Abstract] [Full Text] [Related]
24. Avascular necrosis of the femoral head after treatment of Hodgkin's disease.
Tombolini V; Capua A; Pompili E
Acta Oncol; 1992; 31(1):64-5. PubMed ID: 1375043
[No Abstract] [Full Text] [Related]
25. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
[TBL] [Abstract][Full Text] [Related]
26. Hodgkin's disease, splenectomy and secondary leukemia.
Centurioni R; Brianzoni F; Leoni P; Danieli G
Haematologica; 1993; 78(4):258-9. PubMed ID: 8294062
[No Abstract] [Full Text] [Related]
27. Are ABVD and MOPP/ABV truly equivalent for treating Hodgkin's disease at advanced stages?
Andrieu JM; Colonna P
J Clin Oncol; 1998 Jun; 16(6):2283. PubMed ID: 9626234
[No Abstract] [Full Text] [Related]
28. Chemotherapy of Hodgkin's disease. Maintenance therapy vs no maintenance after remission induction with combination chemotherapy.
Luce JK; Frei E; Gehan EA; Coltman CA; Talley R; Monto RW
Arch Intern Med; 1973 Mar; 131(3):391-5. PubMed ID: 4688037
[No Abstract] [Full Text] [Related]
29. Acute erythroblastic leukemia terminating a very long-lasting (27 years) Hodgkin's disease.
Mantovani G; Del Giacco GS; Marongiu F; Tognella S; Carassi UE
Acta Haematol; 1982; 67(4):287-8. PubMed ID: 6810628
[No Abstract] [Full Text] [Related]
30. Osteonecrosis of sternum and rib in a patient treated for Hodgkin's disease.
Blijham GH; Vermeulen A; Mendes de Leon DE
Cancer; 1985 Nov; 56(9):2292-4. PubMed ID: 3840407
[TBL] [Abstract][Full Text] [Related]
31. Recovery of spermatogenesis after treatment for Hodgkin's disease: limiting dose of MOPP chemotherapy.
da Cunha MF; Meistrich ML; Fuller LM; Cundiff JH; Hagemeister FB; Velasquez WS; McLaughlin P; Riggs SA; Cabanillas FF; Salvador PG
J Clin Oncol; 1984 Jun; 2(6):571-7. PubMed ID: 6547167
[TBL] [Abstract][Full Text] [Related]
32. [Chemotherapy of Hodgkin's disease].
Amiel JL; Mathé G
Rev Prat; 1974 Oct; 24(45):3957-60, 3963-4, 3967-8. PubMed ID: 4141118
[No Abstract] [Full Text] [Related]
33. Is ABVD the standard regimen for Hodgkin's disease based on randomized CALGB comparison of MOPP, ABVD and MOPP alternating with ABVD?
Canellos GP
Leukemia; 1996 Jun; 10 Suppl 2():s68. PubMed ID: 8649055
[No Abstract] [Full Text] [Related]
34. Randomized study for the treatment of advanced Hodgkin's disease: MOPP vs. LOPP.
Avilés A; Díaz-Maqueo JC; García EL; Torras V; López-Vancell D
Arch Invest Med (Mex); 1991; 22(1):45-50. PubMed ID: 1819976
[TBL] [Abstract][Full Text] [Related]
35. Cytotoxic chemotherapy-induced second primary neoplasms: clinical aspects.
Petru E; Schmähl D
Neoplasma; 1991; 38(2):147-55. PubMed ID: 2041574
[TBL] [Abstract][Full Text] [Related]
36. [Acute myeloid leukemia after treatment of Hodgkin's disease].
Carneiro PC; Pereira ED; Mitteldorf CS; Martinez GA; Beitler B; Pozzi DH
Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(2):87-90. PubMed ID: 2616992
[TBL] [Abstract][Full Text] [Related]
37. Two cycles of MOPP and definitive radiotherapy for stage IIIA and IIIB Hodgkin's disease.
Fuller LM; Hagemeister FB
Recent Results Cancer Res; 1989; 117():197-204. PubMed ID: 2602645
[No Abstract] [Full Text] [Related]
38. MOPP/ABV hybrid program: combination chemotherapy based on early introduction of seven effective drugs for advanced Hodgkin's disease.
Klimo P; Connors JM
J Clin Oncol; 1985 Sep; 3(9):1174-82. PubMed ID: 2411881
[TBL] [Abstract][Full Text] [Related]
39. Osteonecrosis of the jaws: a complication of cancer chemotherapy.
Schwartz HC
Head Neck Surg; 1982; 4(3):251-3. PubMed ID: 6896046
[TBL] [Abstract][Full Text] [Related]
40. [10 years of DeVita protocol].
Gassmann W; Schmitz N; Löffler H
Dtsch Med Wochenschr; 1982 Jul; 107(27):1043-4. PubMed ID: 6896303
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
